We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.
- Authors
Maruyama, Riichiroh; Nishiwaki, Yutaka; Tamura, Tomohide; Yamamoto, Nobuyuki; Tsuboi, Masahiro; Nakagawa, Kazuhiko; Shinkai, Tetsu; Negoro, Shunichi; Imamura, Fumio; Eguchi, Kenji; Takeda, Koji; Inoue, Akira; Tomii, Keisuke; Harada, Masao; Masuda, Noriyuki; Jiang, Haiyi; Itoh, Yohji; Ichinose, Yukito; Saijo, Nagahiro; Fukuoka, Masahiro
- Abstract
This phase III study (V-15-32) compared gefitinib (250 mg/d) with docetaxel (60 mg/m(2)) in patients (N = 489) with advanced/metastatic non-small-cell lung cancer (NSCLC) who had failed one or two chemotherapy regimens.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 26, p4244
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.15.0185